TENX · Tenax Therapeutics, Inc.

Summary

Tenax Therapeutics, Inc. filed an 8-K on March 10, 2026, including Exhibit 99.1 press release under Item 2.02, which is not deemed 'filed' for purposes of Section 18 of the Exchange Act. The filing contains no explicit disclosure details on results of operations or other events.

Key takeaways

• Filing date: 2026-03-10
• Form Type: 8-K
• Item 2.02 with Exhibit 99.1 Press release dated March 10, 2026
• Item 9.01 Financial Statements and Exhibits
• Exhibit 104 Cover Page Interactive Data File